$65.56
-1.44[-2.15%]
At close: May 9
$65.56
0[0.00%]
After Hours: 4:00PM EDT
Intra-Cellular Therapies
(NASDAQ:ITCI)Intra-Cellular Therapies Stock (NASDAQ:ITCI), Earnings Estimates, EPS, and Revenue
Intra-Cellular Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS
$-0.160
Quarterly Revenue
$144.9M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$462.2M
Analyze the earnings history of Intra-Cellular Therapies using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?
Intra-Cellular Therapies (ITCI) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Intra-Cellular Therapies (NASDAQ:ITCI)?
The Actual EPS was $-0.16, which beat the estimate of $-0.33.
What were Intra-Cellular Therapies’s (NASDAQ:ITCI) revenues?
The Actual Revenue was $144.9M, which beat the estimate of $140.9M.
Browse earnings estimates, EPS, and revenue on all stocks.